Although High Density Lipoprotein Cholesterol (HDL-C) levels are inversely proportional to
cardiovascular risk in many studies, recent pharmacological interventional studies with HDL …

This review aims to provide an overview on the properties of high‐density lipoproteins
(HDLs) and their cardioprotective effects. Emergent HDL therapies will be presented in the …

An understanding of the atheroprotective mechanisms of HDL is essential for the rational
use of currently available drugs and directed development of new drugs. Increasing total …

Conclusion HDL is clearly a functionally versatile molecule mediating a variety of molecular
processes protective against atherosclerosis. Mechanistic detail continues to greatly enrich …

Population studies from all parts of the world have consistently reported that a low plasma
level of high-density lipoprotein (HDL) cholesterol is a strong predictor of coronary heart …

Plasma measurements of lipids, lipoproteins, and apolipoproteins provide information on the
static levels of these fractions without providing key information on the dynamic fluxes of …

Numerous epidemiological studies have identified high-density lipoprotein cholesterol
(HDL) to be an independent risk factor for coronary heart disease (CHD). HDL is an …

Plasma high density lipoproteins (HDL) are small, dense, protein-rich particles compared
with other lipoprotein classes; roughly half of total HDL mass is accounted for by lipid …

Primary and secondary prevention of coronary heart disease (CHD) has focused on
lowering the LDL fraction of blood lipids not only because of the strong epidemiological …

Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia
that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular …